CBT profiles of cabozantinib approved for advanced renal cell carcinomas

被引：12
|
作者：
Wang, Xiangdong [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Inst Clin Sci, Shanghai Inst Clin Bioinformat, Shanghai, Peoples R China
来源：
CELL BIOLOGY AND TOXICOLOGY | 2016年 / 32卷 / 04期
关键词：
KINASE; INHIBITORS; MEDICINE; GROWTH;
D O I：
10.1007/s10565-016-9349-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：259 / 261
页数：3
相关论文
共 50 条
  • [21] The nivolumab/cabozantinib combination and the future of doublets in advanced renal cell cancer treatment
    Lilly, Eddy
    Sarkis, Julien
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (06) : 1553 - 1554
  • [22] Cabozantinib receives Approval Recommendation of the CHMP for the Treatment of the advanced Renal Cell Carcinoma
    Gerwe, Martin
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (09) : 576 - 576
  • [23] Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma
    Vitale, Maria Giuseppa
    Nasso, Cecilia
    Oltrecolli, Marco
    Baldessari, Cinzia
    Fanelli, Martina
    Dominici, Massimo
    Sabbatini, Roberto
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1183 - 1192
  • [24] MicroRNA profiles of papillary, chromophobe, and conventional renal cell carcinomas
    Tozbikian, Gary
    Liu, Aihua
    Baldwin, Don
    Tobias, John
    Xu, George
    Tomaszewski, John E.
    Lal, Priti
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (04) : 654 - 654
  • [25] Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
    Di Pierro, Giulia
    Mini, Enrico
    Roviello, Giandomenico
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [26] Novel miRNA profiles specific for renal cell carcinomas and upper tract urothelial carcinomas
    Zaravinos, Apostolos
    Lambrou, George I.
    Mourmouras, Nikos
    Katafygiotis, Patroklos
    Papagregoriou, Gregory
    Giannikou, Krinnio
    Delakas, Dimitris
    Deltas, Constantinos
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S20 - S20
  • [27] Cabozantinib for the treatment of renal cell carcinoma
    Escudier, Bernard
    Lougheed, Julie C.
    Albiges, Laurence
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (18) : 2499 - 2504
  • [28] Cabozantinib use in renal cell carcinoma
    Neuwelt, A. J.
    Mathur, S.
    Johnson, A. T.
    Kessler, E. R.
    Bowles, D. W.
    DRUGS OF TODAY, 2017, 53 (05) : 299 - 307
  • [29] Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
    Rathi, Nityam
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3741 - 3749
  • [30] Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma
    Cerbone, Luigi
    Di Nunno, Vincenzo
    Ajuria, Lucia Carril
    Silva, Carolina Alves Costa
    Colomba, Emeline
    Guida, Annalisa
    Salviat, Flore
    Hirsch, Laure
    Benchimol-Zouari, Axelle
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : 80 - 87
12345